可溶性尿体细胞血管紧张素转换酶在子痫前期患者中过度表达：一种疾病的潜在新标志物？
Soluble urinary somatic angiotensin converting enzyme is overexpressed in patients with preeclampsia: a potential new marker for the disease?
机构信息
Division of Nephrology & Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Postgraduate Program in Medicine and Health Sciences, Pontifical Catholic University of Rio Grande Do Sul, Porto Alegre, Brazil.
出版信息
Hypertens Pregnancy. 2022 Aug-Nov;41(3-4):190-197. doi: 10.1080/10641955.2022.2115060. Epub 2022 Aug 23.
Abstract
OBJECTIVE
The aim of this study was to identify and quantify urinary Angiotensin-Converting-Enzyme (ACE) in hypertensive disorders of pregnancy.
METHODS
Urine samples were analyzed by Western blot. Patients were classified into: normotensive pregnancy (N); preeclampsia and superimposed preeclampsia (PE+SPE); and gestational hypertension (GH).
RESULTS
Somatic ACE protein expression was higher in PE+SPE compared to N and GH. There was a positive correlation between ACE and urinary protein to creatinine ratio, systolic and diastolic blood pressures.
CONCLUSION
These results indicate ACE overexpression in the urine of preeclamptic patients and suggest that it may be a new marker for the disease.
摘要
目的
本研究旨在鉴定和定量妊娠高血压疾病患者尿液中的血管紧张素转换酶（ACE）。
方法
采用 Western blot 分析尿液样本。患者分为：正常妊娠（N）；子痫前期和重叠子痫前期（PE+SPE）；和妊娠期高血压（GH）。
结果
PE+SPE 患者尿液中 ACE 蛋白表达高于 N 和 GH。ACE 与尿蛋白与肌酐比值、收缩压和舒张压呈正相关。
结论
这些结果表明子痫前期患者尿液中 ACE 过度表达，并提示其可能是该疾病的新标志物。
相似文献
1
Soluble urinary somatic angiotensin converting enzyme is overexpressed in patients with preeclampsia: a potential new marker for the disease?
Hypertens Pregnancy. 2022 Aug-Nov;41(3-4):190-197. doi: 10.1080/10641955.2022.2115060. Epub 2022 Aug 23.
2
Angiotensin Converting Enzyme 90 kDa isoform: Biomarker for diagnosis of preeclampsia?
Med Hypotheses. 2014 Nov;83(5):526-9. doi: 10.1016/j.mehy.2014.09.009. Epub 2014 Sep 16.
3
Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I- converting enzyme deletion/deletion genotype.
Braz J Med Biol Res. 2007 Apr;40(4):583-90. doi: 10.1590/s0100-879x2007000400018.
4
Prolylcarboxypeptidase gene, chronic hypertension, and risk of preeclampsia.
Am J Obstet Gynecol. 2006 Jul;195(1):162-71. doi: 10.1016/j.ajog.2006.01.079. Epub 2006 May 8.
5
Association of ACE*(Insertion/Deletion) Variant with the Elevated Risk of Preeclampsia Among Gestational Women.
Biochem Genet. 2024 Oct;62(5):3774-3802. doi: 10.1007/s10528-023-10620-5. Epub 2024 Jan 14.
6
Fetal sex and the circulating renin-angiotensin system during early gestation in women who later develop preeclampsia or gestational hypertension.
J Hum Hypertens. 2014 Feb;28(2):133-9. doi: 10.1038/jhh.2013.51. Epub 2013 Jun 20.
7
Evaluation of the renin-angiotensin-aldosterone system in pregnancy complicated by preeclampsia with and without intrauterine growth retardation.
Ann Univ Mariae Curie Sklodowska Med. 2004;59(2):451-6.
8
Determination of renin, angiotensin converting enzyme and angiotensin II levels in human placenta, chorion and amnion from women with pregnancy induced hypertension.
Clin Endocrinol (Oxf). 1996 Apr;44(4):429-33. doi: 10.1046/j.1365-2265.1996.703525.x.
9
Preeclampsia and angiotensin converting enzyme (ACE) I/D and angiotensin II type-1 receptor (AT1R) A1166C polymorphisms: association with ACE I/D polymorphism.
J Renin Angiotensin Aldosterone Syst. 2013 Jun;14(2):174-80. doi: 10.1177/1470320312448950. Epub 2012 Jun 19.
10
Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia.
Am J Obstet Gynecol. 1990 Nov;163(5 Pt 1):1612-21. doi: 10.1016/0002-9378(90)90639-o.
本文引用的文献
1
Novel roles of the renal angiotensin-converting enzyme.
Mol Cell Endocrinol. 2021 Jun 1;529:111257. doi: 10.1016/j.mce.2021.111257. Epub 2021 Mar 26.
2
Causes and Consequences of the Dysregulated Maternal Renin-Angiotensin System in Preeclampsia.
Front Endocrinol (Lausanne). 2019 Sep 10;10:563. doi: 10.3389/fendo.2019.00563. eCollection 2019.
3
Lower circulating angiotensin II levels are related to the severity of preeclampsia and its risk as disclosed by a specific bioassay.
Medicine (Baltimore). 2018 Sep;97(39):e12498. doi: 10.1097/MD.0000000000012498.
4
The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice.
Pregnancy Hypertens. 2018 Jul;13:291-310. doi: 10.1016/j.preghy.2018.05.004. Epub 2018 May 24.
5
A novel rodent model of pregnancy complications associated with genetically determined angiotensin-converting enzyme (ACE) activity.
Am J Physiol Endocrinol Metab. 2018 Jul 1;315(1):E52-E62. doi: 10.1152/ajpendo.00289.2017. Epub 2018 Jan 23.
6
The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP.
Pregnancy Hypertens. 2014 Apr;4(2):97-104. doi: 10.1016/j.preghy.2014.02.001. Epub 2014 Feb 15.
7
Total protein is an effective loading control for cerebrospinal fluid western blots.
J Neurosci Methods. 2015 Aug 15;251:72-82. doi: 10.1016/j.jneumeth.2015.05.011. Epub 2015 May 22.
8
Second trimester angiotensing-converting enzyme and uterine artery Doppler as predictors of preeclampsia in a high-risk population.
Hypertens Pregnancy. 2015 May;34(2):171-80. doi: 10.3109/10641955.2014.988352. Epub 2015 Mar 16.
9
N-domain angiotensin-I converting enzyme is expressed in immortalized mesangial, proximal tubule and collecting duct cells.
Int J Biol Macromol. 2015 Jan;72:380-90. doi: 10.1016/j.ijbiomac.2014.07.043. Epub 2014 Sep 1.
10
Concentrations of endothelial nitric oxide synthase, angiotensin-converting enzyme, vascular endothelial growth factor and placental growth factor in maternal blood and maternal metabolic status in pregnancy complicated by hypertensive disorders.
J Hum Hypertens. 2014 Nov;28(11):670-6. doi: 10.1038/jhh.2014.42. Epub 2014 Sep 4.
Zotero 插件